Key terms
About NUWE
Nuwellis, Inc. operates as a medical device company. It engages in the provision of products for the treatment of fluid overload. The firm's products include Aquadex FlexFlow System, which provides an ultrafiltration for the removal of salt and water in patients with hypervolemia, or fluid overload. It operates through Cardiac and Coronary Disease Products segment. The company was founded by Crispin Marsh and William S. Peters in November 1999 and is headquartered in Eden Prairie, MN.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest NUWE news
Mar 13
2:00am ET
Nuwellis, Inc. on the Brink: Racing Against Time to Avoid Nasdaq Delisting
Mar 12
1:45pm ET
Maxim Group Keeps Their Buy Rating on Nuwellis (NUWE)
Mar 07
9:16am ET
Nuwellis announces results from clinical data anaylses of AVOID-HF trial
Mar 05
8:11am ET
Nuwellis reports Q4 EPS ($2.24), consensus ($1.39)
Feb 22
8:01am ET
Nuwellis partner SeaStar Medical receives FDA HDE for Quelimmune
Feb 07
4:22am ET
Nuwellis Reveals Aquadex System Success in Liver Disease
Feb 06
9:05am ET
Nuwellis announces new case series on potential of Aquadex therapy
Jan 18
9:00am ET
Nuwellis files to sell units, no amount given
Jan 04
3:09pm ET
Nuwellis gets FDA clearance for an additional specialty dELC
No recent press releases are available for NUWE
NUWE Financials
Key terms
Ad Feedback
NUWE Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
NUWE Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
